dalteparin and chondroitin sulfates

dalteparin has been researched along with chondroitin sulfates in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (31.43)18.2507
2000's19 (54.29)29.6817
2010's5 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herzog, S; Kuhn, W; Rath, W1
Humphrey, PW; Keller, MP; Kikta, MJ; Silver, D1
Kwan, YL; Kyle, PW; Manoharan, A; Ramakrishna, R1
Baker, RI; Gilmore, G; Thom, J1
Burgess, JK; Chong, BH1
Peters, FP1
Wade, WE2
Horiuchi, M; Ishida, M; Nakada, Y; Sakamoto, F1
Fernández, JA; Griffin, JH; Petäjä, J1
Neofotistos, D; Ts'ao, CH; Zmuda, K1
Barratt, SM; Edwards, RC; Ruff, SJ1
Keeney, M; Kovacs, MJ1
Goetschel, P; Leumann, E; Neuhaus, TJ; Schmugge, M1
Harrison, SJ; McColl, MD; Rafferty, I1
Gradowski, JF; Martinez, J; San Antonio, JD; Schick, BP1
Büning, H; Gerner, FM; Hacker, UT; Hallek, M; Hutter, M; Reichenspurner, H; Stangl, M1
Fujishima, Y; Miyake, Y; Sukamoto, T; Yokota, K1
Taylor, AA1
Bonneau, JC; Drouet, M; Gay, G; Le Sellin, J; Leclere, JM; Nicolie, B1
Counsell, C; Sandercock, P1
Becker, GJ; McMahon, LP; Polkinghorne, KR1
Bar, J; Blickstein, D; Hod, M1
Mitome, J; Yamamoto, H1
Kossard, S; McGrath, M; Wells, J1
Asada, M; Ebihara, S; Okazaki, T; Sasaki, H; Takahashi, H; Yamaya, M1
Cooper, P; Gatt, A; Kitchen, S; Makris, M; van Veen, JJ; Woolley, AM1
Arvidsson, T; Carlin, G; Ek, M; Hakkarainen, B; McEwen, I; Rundlöf, T1
Jaussaud, M; Léon, A; Lepouse, C; Murat, O; Perrier, S; Petit, JS1
Koyama, T1
Castro-López, V; Hammadi, N; Harris, LF; Killard, AJ; O'Donnell, JS1
Castro-López, V; Harris, LF; Killard, AJ; O'Donnell, JS1
Desai, UR; King, JT1
Bereczky, Z; Boda, Z; Kappelmayer, J; Kerenyi, A; Olah, Z; Szarvas, M1

Reviews

6 review(s) available for dalteparin and chondroitin sulfates

ArticleYear
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
    Thrombosis research, 1998, Feb-15, Volume: 89, Issue:4

    Topics: Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cost-Benefit Analysis; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; MEDLINE; Thrombophlebitis

1998
Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
    American journal of orthopedics (Belle Mead, N.J.), 1999, Volume: 28, Issue:4

    Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Chondroitin Sulfates; Cost-Benefit Analysis; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparinoids; Heparitin Sulfate; Humans; Treatment Outcome; Venous Thrombosis

1999
[Delayed hypersensitivity to heparins and heparinoids].
    Allergie et immunologie, 2002, Volume: 34, Issue:2

    Topics: Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Enoxaparin; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Hypersensitivity, Delayed; Nadroparin; Recombinant Proteins; Skin Tests

2002
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Stroke, 2002, Volume: 33, Issue:7

    Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Databases, Factual; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Odds Ratio; Pulmonary Embolism; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Venous Thrombosis

2002
[Anticoagulant].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 5

    Topics: Animals; Anticoagulants; Antithrombins; Arginine; Benzamidines; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Design; Enoxaparin; Extracorporeal Circulation; Guanidines; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Pipecolic Acids; Protease Inhibitors; Protein C; Recombinant Proteins; Sorption Detoxification; Sulfonamides; Thrombomodulin

2004
[Treatment of disseminated intravascular coagulation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:1

    Topics: Anticoagulants; Antithrombins; Benzamidines; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Heparitin Sulfate; Humans; Protease Inhibitors; Protein C; Recombinant Proteins; Thrombomodulin; Tretinoin

2010

Trials

1 trial(s) available for dalteparin and chondroitin sulfates

ArticleYear
Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:5

    Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Enoxaparin; Factor Xa Inhibitors; Female; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Renal Dialysis

2002

Other Studies

28 other study(ies) available for dalteparin and chondroitin sulfates

ArticleYear
[Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
    Geburtshilfe und Frauenheilkunde, 1995, Volume: 55, Issue:3

    Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Heparin; Heparitin Sulfate; Humans; Platelet Count; Pre-Eclampsia; Pregnancy; Puerperal Disorders; Thrombocytopenia; Thromboembolism

1995
Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
    Surgery, 1993, Volume: 114, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia

1993
Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
    British journal of haematology, 1995, Volume: 91, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Interactions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia

1995
Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
    Thrombosis and haemostasis, 1996, Volume: 75, Issue:2

    Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Susceptibility; Factor V Deficiency; False Negative Reactions; Heparin; Heparin Lyase; Heparitin Sulfate; Heterozygote; Humans; Partial Thromboplastin Time; Polysaccharide-Lyases; Protein C; Reagent Kits, Diagnostic; Sensitivity and Specificity; Thromboembolism

1996
The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
    European journal of haematology, 1997, Volume: 58, Issue:4

    Topics: Adenosine Diphosphate; Adult; Aged; Anticoagulants; Chondroitin Sulfates; Critical Illness; Dalteparin; Dermatan Sulfate; Drug Synergism; Enoxaparin; Epinephrine; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation; Reference Values

1997
Treatment of heparin-induced thrombocytopenia.
    The Journal of thoracic and cardiovascular surgery, 1997, Volume: 114, Issue:3

    Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Heparin; Heparinoids; Heparitin Sulfate; Humans; Thrombocytopenia

1997
Ardeparin and danaparoid for prevention of deep vein thrombosis.
    The Medical letter on drugs and therapeutics, 1997, Oct-10, Volume: 39, Issue:1011

    Topics: Abdomen; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombocytopenia; Thrombophlebitis

1997
Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:8

    Topics: Animals; Anticoagulants; Blood Coagulation; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Factor X; Heparin; Heparitin Sulfate; Injections, Intravenous; Male; Rabbits

1998
Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:5

    Topics: Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cattle; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dextran Sulfate; Drug Synergism; Enoxaparin; Enzyme Activation; Factor V; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Nadroparin; Protein C; Sharks; Structure-Activity Relationship; Swine; Thromboplastin; Tinzaparin

1999
Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    American journal of clinical pathology, 2000, Volume: 113, Issue:5

    Topics: Antibodies; Anticoagulants; Autoantibodies; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin Lyase; Heparinoids; Heparitin Sulfate; Humans; Partial Thromboplastin Time; Platelet Factor 4; Protamines; Prothrombin Time; Thrombelastography

2000
Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
    The Medical journal of Australia, 2000, May-01, Volume: 172, Issue:9

    Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enoxaparin; Female; Heparitin Sulfate; Humans; Middle Aged; Platelet Count; Radionuclide Imaging; Thrombocytopenia; Warfarin

2000
Inter-assay and instrument variability of anti-Xa--results.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Anticoagulants; Blood Coagulation Tests; Chondroitin Sulfates; Chromogenic Compounds; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Monitoring; Factor Xa Inhibitors; Heparitin Sulfate; Humans; Reproducibility of Results

2000
Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
    Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:8-9

    Topics: Adolescent; Anticoagulants; Child; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Platelet Count; Renal Dialysis; Thrombocytopenia

2000
Management of heparin allergy during pregnancy with danaparoid.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2001, Volume: 12, Issue:2

    Topics: Adult; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Enoxaparin; Factor V; Factor Xa Inhibitors; Female; Gestational Age; Heparitin Sulfate; Heterozygote; Humans; Injections, Subcutaneous; Milk, Human; Mutation; Pregnancy; Venous Thrombosis

2001
Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans.
    Thrombosis and haemostasis, 2001, Volume: 85, Issue:3

    Topics: Amino Acid Sequence; Animals; Anticoagulants; Binding Sites; Chondroitin Sulfates; Consensus Sequence; Dermatan Sulfate; Drug Design; Enoxaparin; Factor X; Glycosaminoglycans; Heparin; Heparin Antagonists; Heparitin Sulfate; Humans; Mice; Molecular Sequence Data; Peptides; Rats; Thrombin

2001
Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors.
    Gene therapy, 2001, Volume: 8, Issue:12

    Topics: Anticoagulants; Chondroitin Sulfates; Dependovirus; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Genetic Vectors; HeLa Cells; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Recombinant Proteins; Tinzaparin; Transduction, Genetic

2001
The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2001, Volume: 12, Issue:5

    Topics: Animals; Anticoagulants; Antithrombin III; Bleeding Time; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Models, Animal; Disseminated Intravascular Coagulation; Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Factor Xa; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Kinetics; Male; Platelet Aggregation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin

2001
Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
    BJOG : an international journal of obstetrics and gynaecology, 2001, Volume: 108, Issue:9

    Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Female; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Venous Thrombosis

2001
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:8

    Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, Combination; Eczema; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications

2003
Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.
    The Australasian journal of dermatology, 2005, Volume: 46, Issue:3

    Topics: Abdominal Wall; Adjuvants, Immunologic; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Injections, Subcutaneous; Interferon beta-1b; Interferon-beta; Middle Aged; Mucinoses; Multiple Sclerosis; Thrombosis; Treatment Outcome; Ulcer

2005
A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
    British journal of pharmacology, 2005, Volume: 146, Issue:3

    Topics: Animals; Anticoagulants; Bleeding Time; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Endothelial Cells; Factor X; Gene Expression Regulation, Enzymologic; Glucuronidase; Heparin; Heparitin Sulfate; Humans; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; RNA, Messenger; Tumor Burden; Vascular Endothelial Growth Factor A

2005
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:2

    Topics: Anticoagulants; Blood Coagulation Factors; Blood Coagulation Tests; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Drug Monitoring; Enoxaparin; Factor VIIa; Factor Xa; Fondaparinux; Heparin; Heparin Antagonists; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; In Vitro Techniques; Partial Thromboplastin Time; Polysaccharides; Protamines; Recombinant Proteins; Thrombin; Tinzaparin

2008
Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin.
    Journal of pharmaceutical and biomedical analysis, 2009, Apr-05, Volume: 49, Issue:3

    Topics: Anticoagulants; Calcium; Carbohydrate Sequence; Chondroitin Sulfates; Drug Contamination; Heparin; Magnetic Resonance Spectroscopy; Methylation; Molecular Sequence Data; Nadroparin; Sulfates

2009
[Headaches in a 21-year-old man with Goodpasture disease].
    Annales francaises d'anesthesie et de reanimation, 2009, Volume: 28, Issue:9

    Topics: Anti-Glomerular Basement Membrane Disease; Anticoagulants; Chondroitin Sulfates; Combined Modality Therapy; Dermatan Sulfate; Diabetes Insipidus, Neurogenic; Disseminated Intravascular Coagulation; Enoxaparin; Fatal Outcome; Headache; Heparin; Heparitin Sulfate; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Plasma Exchange; Platelet Factor 4; Sinus Thrombosis, Intracranial; Thrombocytopenia; Young Adult

2009
Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.
    Talanta, 2010, Jun-15, Volume: 81, Issue:4-5

    Topics: Anticoagulants; Chemistry Techniques, Analytical; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa; Fluorescent Dyes; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Kinetics; Reproducibility of Results; Software; Tinzaparin

2010
Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.
    Analytical and bioanalytical chemistry, 2011, Volume: 399, Issue:2

    Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Fluorescent Dyes; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfonamides; Tinzaparin

2011
Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.
    Electrophoresis, 2011, Volume: 32, Issue:21

    Topics: Amines; Chondroitin Sulfates; Electrophoresis, Capillary; Enoxaparin; Heparin, Low-Molecular-Weight; Molecular Conformation; Polymers

2011
Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
    Archives of pathology & laboratory medicine, 2013, Volume: 137, Issue:7

    Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Factor Xa Inhibitors; False Positive Reactions; Fondaparinux; Heparitin Sulfate; Hirudins; Humans; Lupus Coagulation Inhibitor; Mass Screening; Pipecolic Acids; Polysaccharides; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin

2013
chemdatabank.com